Skip to main content
Clinical Trials/IRCT20190621043962N1
IRCT20190621043962N1
Recruiting
未知

Evaluation of the effects of add-on treatment with Atorvastatin on cognitive deficits in schizophrenic patients

Mashhad University of Medical Sciences0 sites64 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
64
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of schizophrenia based on DSM\-5
  • patients between 18 and 64 years
  • Informed consent by the patients and a member of his/her family
  • Minimum eighth grade education
  • No psychiatric comorbidity
  • No medical comorbidity
  • No substance use, except for cigarettes
  • No history of hypersensitivity reaction or intolerable side effects with Atorvastatin
  • No concomitant drugs that they interact with Atorvastatin (Anti\-inflammatory drugs such as Aspirin and Ibuprofen, Thiazide diuretics, weight\-loss drugs, anti\-fungal drugs, Macrolids, Colchicin, Protease inhibitors)
  • No pregnancy or breastfeeding (for women)

Exclusion Criteria

  • Failure to the patient or his/her family to continue the study
  • Occurrence of any serious side effects during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Tolerance and effect of an add-on therapy with an ivy leaves dry extract syrup on lung function in children with asthma.Pediatric patients age 6-12 yrs with uncontrolled mild persistent asthmaMedDRA version: 14.1Level: LLTClassification code 10003555Term: Asthma bronchialSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2011-003894-27-DETechnische Universität Dresden
Completed
Phase 2
Evaluation the effect of complementary treatment with pistacia atlantica mouthwash on chemotherapy-induced mucositisCondition 1: chemotherapy-induced mucositis. Condition 2: Xerostomia.Oral mucositis (ulcerative)Disturbances of salivary secretion
IRCT20160731029133N5Zanjan University of Medical Sciences30
Completed
Not Applicable
A clinical trial to compare the effect of omega 3 fatty acids between diabetic dyslipidemic patients and non- diabetic dyslipidemic patientsHealth Condition 1: E785- Hyperlipidemia, unspecified
CTRI/2020/01/022594Dr E Hephzibah Magdalene53
Not yet recruiting
Phase 3
Evaluating the effect of low-level laser versus ozone in patients with Medication-related osteonecrosis of the jaw who were treated with debridement surgery and Platelet-rich fibriM87.1Condition 1: Osteonecrosis. Condition 2: Pain in jaw. Condition 3: Soft tissue dehiscence.Osteonecrosis due to drugsDisease of jaws, unspecifiedSoft tissue disorder, unspecifiedK10.9M79.9
IRCT20150613022697N13Mashhad University of Medical Sciences30
Completed
Not Applicable
Testing the effectiveness of an add-on treatment for impingement syndrome stage I and II - Marnitz therapy as a combination partner for standardized physiotherapy - Pilot StudyM75.4Impingement syndrome of shoulder
DRKS00005338Institut für Gesundheits- und PflegewissenschaftMedizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg18